FLT3 D835 Mutations Confer Differential Resistance to Type II FLT3 Inhibitors

by Smith, Catherine C., Lin, Kimberly, Stecula, Adrian, Sali, Andrej, Shah, Neil P.
Published 2015

Overcoming myelosuppression due to synthetic lethal toxicity for FLT3-targeted acute myeloid leukemia therapy

by Warkentin, Alexander A, Lopez, Michael S, Lasater, Elisabeth A, Lin, Kimberly, He, Bai-Liang, Leung, Anskar YH, Smith, Catherine C, Shah, Neil P, Shokat, Kevan M
Published 2014